Posts By: North Shore-LIJ

New Study Reveals Promising Diabetes Prevention Strategies

A new study focusing on patients with pre-diabetes concentrates on aggressive glucose-lowering treatments to achieve normal glucose levels in people with pre-diabetes to achieve maximum reductions in progression to diabetes in the long-term. The study has some promising results. People with pre-diabetes (a high risk state for overt type 2 diabetes) who experience a period… Read more »

Flame Retardants Don’t Stop Fire, Can Cause Illness

Brominated flame retardants are back in the news, thanks to a recent series in the Chicago Tribune and a New York Times Op-Ed column. Though their purported function is noble—to limit flammability, thereby reducing harm—brominated flame retardants (sometimes called PBDEs) pose risks of their own. Evidence already shows that exposure to these chemicals is linked… Read more »

Response to First Treatment May Predict Epilepsy’s Course

In patients diagnosed with epilepsy, the likelihood that they will continue to have seizures may well depend on their response to the initial anti-seizure medication given after their diagnosis. According to a recent study published in Neurology, researchers found that 50 percent of the people in the study were seizure-free after the first medication they… Read more »

World No Tobacco Day

We observe World No Tobacco Day each May to increase awareness about health problems caused by tobacco use. This year, the World Health Organization’s (WHO) “tobacco industry interference” theme highlights the tobacco industry’s efforts to thwart tobacco control policies around the world and reminds organizations and governments of their responsibility to be vigilant against the… Read more »

Frequent Dental X-Rays Linked to Most Common Brain Tumor

People who received frequent dental x-rays in the past have an increased risk of developing a meningioma, the most commonly diagnosed primary brain tumor, according to a recent study published in Cancer, a peer-reviewed journal of the American Cancer Society. Researchers from the Yale University School of Medicine in New Haven and Brigham and Women’s… Read more »

Buffett’s Prostate Cancer Is Not a Death Knell

Warren Buffett has announced to shareholders that he has the most common cancer in men, Stage 1 prostate cancer. The information he released is insufficient to determine prognosis let alone what treatment is needed, if any. However, statistics are generally on Mr. Buttett’s side. Autopsy studies show that most men will eventually present with prostate… Read more »